These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38954637)

  • 1. YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma.
    Li Z; Su P; Yu M; Zhang X; Xu Y; Jia T; Yang P; Zhang C; Sun Y; Li X; Yang H; Ding Y; Zhuang T; Guo H; Zhu J
    Sci Signal; 2024 Jul; 17(843):eadk0231. PubMed ID: 38954637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
    Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.
    Vargas RE; Duong VT; Han H; Ta AP; Chen Y; Zhao S; Yang B; Seo G; Chuc K; Oh S; El Ali A; Razorenova OV; Chen J; Luo R; Li X; Wang W
    EMBO J; 2020 Jan; 39(1):e102406. PubMed ID: 31782549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.
    Lin M; Zheng X; Yan J; Huang F; Chen Y; Ding R; Wan J; Zhang L; Wang C; Pan J; Cao X; Fu K; Lou Y; Feng XH; Ji J; Zhao B; Lan F; Shen L; He X; Qiu Y; Jin J
    Nat Commun; 2024 Jun; 15(1):4995. PubMed ID: 38862474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors.
    Akrida I; Makrygianni M; Nikou S; Mulita F; Bravou V; Papadaki H
    Pathol Res Pract; 2024 Oct; 262():155551. PubMed ID: 39153238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcription.
    Kulkarni A; Mohan V; Tang TT; Post L; Chan YC; Manning M; Thio N; Parker BL; Dawson MA; Rosenbluh J; Vissers JH; Harvey KF
    EMBO Rep; 2024 Sep; 25(9):3944-3969. PubMed ID: 39103676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells.
    Li S; Li X; Yang YB; Wu SF
    Apoptosis; 2024 Aug; 29(7-8):1198-1210. PubMed ID: 38553612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers.
    Chapeau EA; Sansregret L; Galli GG; Chène P; Wartmann M; Mourikis TP; Jaaks P; Baltschukat S; Barbosa IAM; Bauer D; Brachmann SM; Delaunay C; Estadieu C; Faris JE; Furet P; Harlfinger S; Hueber A; Jiménez Núñez E; Kodack DP; Mandon E; Martin T; Mesrouze Y; Romanet V; Scheufler C; Sellner H; Stamm C; Sterker D; Tordella L; Hofmann F; Soldermann N; Schmelzle T
    Nat Cancer; 2024 Jul; 5(7):1102-1120. PubMed ID: 38565920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y
    J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.
    Marikawa Y; Alarcon VB
    Mol Hum Reprod; 2019 Feb; 25(2):43-60. PubMed ID: 30395288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
    Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
    Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the YAP/KLF5 transcriptional cascade in renal tubular cells aggravates kidney injury.
    Liu Y; Wang Y; Xu C; Zhang Y; Wang Y; Qin J; Lan HY; Wang L; Huang Y; Mak KK; Zheng Z; Xia Y
    Mol Ther; 2024 May; 32(5):1526-1539. PubMed ID: 38414248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
    Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
    Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEAD mediates YAP-dependent gene induction and growth control.
    Zhao B; Ye X; Yu J; Li L; Li W; Li S; Yu J; Lin JD; Wang CY; Chinnaiyan AM; Lai ZC; Guan KL
    Genes Dev; 2008 Jul; 22(14):1962-71. PubMed ID: 18579750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP inhibits NF-κB signaling and ccRCC growth by opposing p65-ZHX2 cooperativity.
    Li X; Cho YS; Liu Y; Yang Y; Zhuo S; Jiang J
    bioRxiv; 2024 Jun; ():. PubMed ID: 38979373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
    Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
    Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EIF4A3-Induced Upregulation of hsa_circ_0049396 Attenuates the Tumorigenesis of Nasopharyngeal Carcinoma by Regulating the Hippo-YAP Pathway.
    Zhou Q; Cai B; Liu K; Chen H
    DNA Cell Biol; 2024 Oct; 43(10):510-519. PubMed ID: 39133108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic Hedgehog-Smoothened Signaling Depends on YAP1‒TAZ/TEAD Transcription to Restrain Differentiation in Basal Cell Carcinoma.
    Yuan Y; Salinas Parra N; Chen Q; Iglesias-Bartolome R
    J Invest Dermatol; 2022 Jan; 142(1):65-76.e7. PubMed ID: 34293352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S
    EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
    Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
    Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.